AcornMed (金橡医学) Company Profile: Funding, Investors & Partnerships

AcornMed (金橡医学)

As one of the few leading NGS medical service companies in the industry, both solid tumors and blood tumors, AcornMed has launched more than 30 kinds of detection products, involving early diagnosis and early screening, genetic judgment, targeting and immunotherapy of multiple cancers.As one of the few leading NGS medical service companies in the industry, both solid tumors and blood Show More

Alpha Score

64.9

Total Funding$ 43.49 M